Cargando…

New type of RNA virus replication inhibitor based on decahydro-closo-decaborate anion containing amino acid ester pendant group

In this work, a synthetic approach to prepare an example of new class of the derivatives of the closo-decaborate anion with amino acids detached from the boron cluster by pendant group has been proposed and implemented. Compound Na(2)[B(10)H(9)–O(CH(2))(4)C(O)–His–OMe] was isolated and characterized...

Descripción completa

Detalles Bibliográficos
Autores principales: Avdeeva, Varvara V., Garaev, Timur M., Breslav, Natalia V., Burtseva, Elena I., Grebennikova, Tatyana V., Zhdanov, Andrei P., Zhizhin, Konstantin Yu., Malinina, Elena A., Kuznetsov, Nikolay T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948040/
https://www.ncbi.nlm.nih.gov/pubmed/35332377
http://dx.doi.org/10.1007/s00775-022-01937-4
_version_ 1784674581392392192
author Avdeeva, Varvara V.
Garaev, Timur M.
Breslav, Natalia V.
Burtseva, Elena I.
Grebennikova, Tatyana V.
Zhdanov, Andrei P.
Zhizhin, Konstantin Yu.
Malinina, Elena A.
Kuznetsov, Nikolay T.
author_facet Avdeeva, Varvara V.
Garaev, Timur M.
Breslav, Natalia V.
Burtseva, Elena I.
Grebennikova, Tatyana V.
Zhdanov, Andrei P.
Zhizhin, Konstantin Yu.
Malinina, Elena A.
Kuznetsov, Nikolay T.
author_sort Avdeeva, Varvara V.
collection PubMed
description In this work, a synthetic approach to prepare an example of new class of the derivatives of the closo-decaborate anion with amino acids detached from the boron cluster by pendant group has been proposed and implemented. Compound Na(2)[B(10)H(9)–O(CH(2))(4)C(O)–His–OMe] was isolated and characterized. This compound has an inorganic hydrophobic core which is the 10-vertex boron cage and the –O(CH(2))(4)C(O)–His–OMe organic substituent. It has been shown to possess strong antiviral activity in vitro against modern strains of A/H1N1 virus at 10 and 5 µg/mL. The compound has been found to be non-cytotoxic up to 160 µg/mL. At the same time, the compound has been found to be inactive against SARS-CoV-2, indicating specific activity against RNA virus replication. Molecular docking of the target derivative of the closo-decaborate anion with a model of the transmembrane region of the M2 protein has been performed and the mechanism of its antiviral action is discussed. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00775-022-01937-4.
format Online
Article
Text
id pubmed-8948040
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-89480402022-03-25 New type of RNA virus replication inhibitor based on decahydro-closo-decaborate anion containing amino acid ester pendant group Avdeeva, Varvara V. Garaev, Timur M. Breslav, Natalia V. Burtseva, Elena I. Grebennikova, Tatyana V. Zhdanov, Andrei P. Zhizhin, Konstantin Yu. Malinina, Elena A. Kuznetsov, Nikolay T. J Biol Inorg Chem Original Paper In this work, a synthetic approach to prepare an example of new class of the derivatives of the closo-decaborate anion with amino acids detached from the boron cluster by pendant group has been proposed and implemented. Compound Na(2)[B(10)H(9)–O(CH(2))(4)C(O)–His–OMe] was isolated and characterized. This compound has an inorganic hydrophobic core which is the 10-vertex boron cage and the –O(CH(2))(4)C(O)–His–OMe organic substituent. It has been shown to possess strong antiviral activity in vitro against modern strains of A/H1N1 virus at 10 and 5 µg/mL. The compound has been found to be non-cytotoxic up to 160 µg/mL. At the same time, the compound has been found to be inactive against SARS-CoV-2, indicating specific activity against RNA virus replication. Molecular docking of the target derivative of the closo-decaborate anion with a model of the transmembrane region of the M2 protein has been performed and the mechanism of its antiviral action is discussed. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00775-022-01937-4. Springer International Publishing 2022-03-25 2022 /pmc/articles/PMC8948040/ /pubmed/35332377 http://dx.doi.org/10.1007/s00775-022-01937-4 Text en © The Author(s), under exclusive licence to Society for Biological Inorganic Chemistry (SBIC) 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Paper
Avdeeva, Varvara V.
Garaev, Timur M.
Breslav, Natalia V.
Burtseva, Elena I.
Grebennikova, Tatyana V.
Zhdanov, Andrei P.
Zhizhin, Konstantin Yu.
Malinina, Elena A.
Kuznetsov, Nikolay T.
New type of RNA virus replication inhibitor based on decahydro-closo-decaborate anion containing amino acid ester pendant group
title New type of RNA virus replication inhibitor based on decahydro-closo-decaborate anion containing amino acid ester pendant group
title_full New type of RNA virus replication inhibitor based on decahydro-closo-decaborate anion containing amino acid ester pendant group
title_fullStr New type of RNA virus replication inhibitor based on decahydro-closo-decaborate anion containing amino acid ester pendant group
title_full_unstemmed New type of RNA virus replication inhibitor based on decahydro-closo-decaborate anion containing amino acid ester pendant group
title_short New type of RNA virus replication inhibitor based on decahydro-closo-decaborate anion containing amino acid ester pendant group
title_sort new type of rna virus replication inhibitor based on decahydro-closo-decaborate anion containing amino acid ester pendant group
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948040/
https://www.ncbi.nlm.nih.gov/pubmed/35332377
http://dx.doi.org/10.1007/s00775-022-01937-4
work_keys_str_mv AT avdeevavarvarav newtypeofrnavirusreplicationinhibitorbasedondecahydroclosodecaborateanioncontainingaminoacidesterpendantgroup
AT garaevtimurm newtypeofrnavirusreplicationinhibitorbasedondecahydroclosodecaborateanioncontainingaminoacidesterpendantgroup
AT breslavnataliav newtypeofrnavirusreplicationinhibitorbasedondecahydroclosodecaborateanioncontainingaminoacidesterpendantgroup
AT burtsevaelenai newtypeofrnavirusreplicationinhibitorbasedondecahydroclosodecaborateanioncontainingaminoacidesterpendantgroup
AT grebennikovatatyanav newtypeofrnavirusreplicationinhibitorbasedondecahydroclosodecaborateanioncontainingaminoacidesterpendantgroup
AT zhdanovandreip newtypeofrnavirusreplicationinhibitorbasedondecahydroclosodecaborateanioncontainingaminoacidesterpendantgroup
AT zhizhinkonstantinyu newtypeofrnavirusreplicationinhibitorbasedondecahydroclosodecaborateanioncontainingaminoacidesterpendantgroup
AT malininaelenaa newtypeofrnavirusreplicationinhibitorbasedondecahydroclosodecaborateanioncontainingaminoacidesterpendantgroup
AT kuznetsovnikolayt newtypeofrnavirusreplicationinhibitorbasedondecahydroclosodecaborateanioncontainingaminoacidesterpendantgroup